Alpha Tau Medical Ltd..
DRTS.US | Manufacture of medical and dental instruments and supplies
Alpha Tau Medical Ltd. is a medical device company specializing in the research, development, and commercialization of alpha-radiation cancer therapies. Their primary product, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver localized alpha radiation directly to solid ...Show More
Better Health for All
0
Insufficient evidence to determine a value score for Alpha Tau Medical Ltd. regarding Better Health for All. No articles or relevant information found. A neutral score of 0 is assigned.
Materiality Analysis: Company Summary: Alpha Tau Medical Ltd. is a clinical-stage oncology company focused on developing and commercializing Alpha DaRT, a diffusing alpha-emitters radiation therapy for solid cancers. Their technology is currently in clinical trials targeting various cancers, including skin, oral, pancreatic, prostate, lung, liver, and breast cancers, with preclinical studies exploring other applications. The company is based in Israel and operates within the oncology therapeutics sector.
Peer Comparison: Compared to other oncology therapeutics companies, Alpha Tau's focus on alpha-emitter technology is relatively unique. Many peers focus on chemotherapy, immunotherapy, or targeted small molecule therapies. Its potential to treat a range of solid tumors positions it competitively, assuming successful trial outcomes and regulatory approvals.
Materiality Assessment: The business model is fundamentally supportive of the "Better Health for All" value, with a high level of materiality.
Detailed Rationale: Alpha Tau's core business directly addresses the "Better Health for All" value by developing a novel cancer treatment. Cancer significantly impacts global health, and innovative therapies like Alpha DaRT have the potential to improve patient outcomes and survival rates. The company's focus on various solid tumors suggests a broad applicability, potentially benefiting a large patient population. While still in clinical trials, successful commercialization could improve access to advanced cancer care. The company's research and development efforts align with improving health outcomes. The success of Alpha DaRT in clinical trials and its subsequent accessibility and affordability will determine the extent of its positive impact.
Value Interaction Notes: N/A
Scoring Boundary Flags: A score below 5 would be illogical, given the company's direct involvement in developing cancer treatments. A score above 8 should be supported by evidence of successful clinical trials and clear plans for accessibility and affordability.
Fair Money & Economic Opportunity
0
No evidence available to assess Alpha Tau Medical Ltd. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
Alpha Tau Medical Ltd. has not disclosed specific, quantitative data for most 'Fair Pay & Worker Respect' KPIs.
1
While financial reports indicate changes in employee compensation and benefits expenses for various departments for the six and nine months ended September 30, 2025, these do not provide specific metrics for living wage coverage, pay equity, or other worker welfare indicators.
2
Employee reviews mention 'low salary' as a concern, but no specific salary figures or company-wide data are provided.
3
The CEO's total compensation was reported as $649.00k, but median employee compensation is not disclosed, preventing the calculation of a pay ratio.
4
There is no information available regarding collective bargaining, safety incident rates, worker engagement, turnover, insecure contracts, or health insurance coverage.
5
However, multiple articles explicitly state that no specific regulatory actions, violations, fines, or compliance issues related to labor laws have been mentioned.
6
Fair Trade & Ethical Sourcing
0
No information is available in the provided articles regarding any of the KPIs for Fair Trade & Ethical Sourcing, including fair-trade certification share, audit frequency, forced/child labor incidents, traceability coverage, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend.
1
Honest & Fair Business
-50
The company has policies in place to handle allegations of impropriety or non-compliance, which include encouraging anonymous reporting.
1
Data related to complaints is handled securely and confidentially, with specific sensitivity to EU/UK data protection rules.
2
However, there is no evidence regarding the independence of investigation processes for these reports.
Kind to Animals
0
No evidence available to assess Alpha Tau Medical Ltd. on Kind to Animals.
No War, No Weapons
0
Alpha Tau Medical Ltd. is a medical device company focused on alpha-radiation cancer therapies.
1
The provided articles do not contain any explicit evidence regarding the company's involvement in arms manufacturing, military contracts, dual-use technology with military applications, sales to embargoed regimes, or any other activities related to war or weapons. Therefore, no KPIs can be scored based on the provided evidence.
Planet-Friendly Business
0
No information is available in the provided articles regarding DRTS.US's environmental performance or sustainability initiatives. The articles mention the company's radioactive license amendments and approvals from the Israeli Ministry of Environmental Protection and the Massachusetts Department of Public Health, as well as increased production capacity.
1
However, these facts do not provide specific data points for any of the Planet-Friendly Business KPIs, such as emissions, renewable energy use, water consumption, waste diversion, green building certifications, or climate targets.
Respect for Cultures & Communities
0
No evidence available to assess Alpha Tau Medical Ltd. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Alpha Tau Medical Ltd. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
Alpha Tau Medical demonstrates compliant hazardous waste management by securing a radioactive material license from the State of New Hampshire and having its radioactive license amended and pre-clinical laboratory approved by the Israeli Ministry of Environmental Protection.
1
The company's operational procedures outline best practices for handling radioactive materials, including waste management, contamination control, and personnel safety, emphasizing local regulatory compliance.
2
No waste disposal violations or citations were reported in the provided articles.